Latest Forum Topics /
EFH Ltd
Last:0.046
-0.003
|
 Post Reply
|
|
BIO PHARMA company do research on MEDICAL DISEASES
|
|||||
|
wolverine23
Supreme |
03-May-2020 20:19
Yells: "Medical Bull 2020 !!!!!!!! = Internet Bull 2000 !!!!!!!!" |
||||
|
x 0
x 0 Alert Admin |
indeed good news. but is it for bio test kits?
|
||||
| Useful To Me Not Useful To Me | |||||
|
actan99
Master |
03-May-2020 19:40
|
||||
|
x 0
x 0 Alert Admin |
This is defintely big news for both Biolidics and AYTU bIosciences. Cardina Health Inc, is a big global group ( public traded) with yearly revenues of Hundreds of BILLIONS. (Look into wikipedia). Mount Sinai Hospital is also a big name non for profit group, in Amercia, which is also partnering with AYTU ( Biolidics distributor for test kits in the USA) for their research into Heal Light. This AYTU bioscience, looks to have good connections, which is good for business.
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
98mich98
Master |
03-May-2020 19:08
|
||||
|
x 0
x 0 Alert Admin |
Indonesia is using bio. Per test is $58 IG got photo n receipt proof. Refer back to before crash posting. Price crash was.due to BBs. The company is doing fine. | ||||
| Useful To Me Not Useful To Me | |||||
|
ST3-trading
Senior |
03-May-2020 19:01
|
||||
|
x 0
x 0 Alert Admin |
Hope aytu will order more very soon . since the reseller is medical supply to 75% to hospital of untied state
|
||||
| Useful To Me Not Useful To Me | |||||
|
commando
Master |
03-May-2020 18:53
|
||||
|
x 0
x 0 Alert Admin |
Wahhhh....gd news
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
dandanb
Member |
03-May-2020 18:48
|
||||
|
x 0
x 0 Alert Admin |
Saw photos on the delivery of test kits which were posted on social media last week
|
||||
| Useful To Me Not Useful To Me | |||||
|
ST3-trading
Senior |
03-May-2020 18:42
|
||||
|
x 0
x 0 Alert Admin |
How u know
|
||||
| Useful To Me Not Useful To Me | |||||
|
dandanb
Member |
03-May-2020 18:37
|
||||
|
x 0
x 0 Alert Admin |
Bio seems to have delivered one batch of test kits to a hospital in Philippines Cebu City. Maybe for mass testing starting tomorrow. | ||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
WL123456
Supreme |
03-May-2020 18:05
|
||||
|
x 0
x 0 Alert Admin |
US FDA has approved and America will be using this.
Reuters) - Roche Holding AG (S:ROG) received emergency use approval from the U.S. Food and Drug Administration (FDA) for an antibody test to help determine if people have ever been infected with the coronavirus, the Swiss drugmaker said http://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u= on Sunday. |
||||
| Useful To Me Not Useful To Me | |||||
|
Justice888
Supreme |
03-May-2020 15:38
|
||||
|
x 0
x 0 Alert Admin |
Developing tests to diagnose Covid-19 in minutes
In an outbreak of an infectious disease like Covid-19, diagnosing patients is a key first step to preventing its spread. Identifying infected patients allows doctors to quickly ring-fence them, so they do not spread the virus to others while they are being treated. The current "gold standard" method using polymerase chain reaction (PCR) technology detects the presence of viral genetic material in patient samples, but it is time-consuming and technical, since it involves expensive machinery that also requires trained technicians to operate. Now, at least two research groups in Singapore are working on speeding up this process with test kits that can show results in minutes, instead of the current day-long wait for PCR test results. One test being developed by researchers at the Nanyang Technological University (NTU) and Singapore-MIT Alliance for Research and Technology (Smart) could even be as fuss-free as a pregnancy test kit, yielding results in 10 minutes. Their test kit is made of paper coated with molecules that "recognise" Sars-CoV-2 - the virus that causes Covid-19 - proteins in a clinical sample. If the viral proteins are detected, the paper strip changes from white to blue. A key difference between this work-in-progress test and the PCR test is the part of the virus that is being detected, explains research team member, Professor Peter Preiser, associate vice-president for biomedical and life sciences at NTU. Sars-CoV-2 comprises a single-stranded genetic material known as RNA, as well as proteins. "The PCR test detects the RNA of the virus. The test we are working on detects proteins of the virus." The principle behind this test, he explains, is to use the coated paper to capture all the viral proteins in a sample and then detect this captured protein via a visual read-out. This may sound simple in theory but plenty of research went into it. First, scientists developed molecules that could be very specific about "recognising" the viral proteins, so that false positives did not occur due to other proteins in blood or other samples. They also identified molecules that could be used to flag the viral proteins that are captured, which causes the test kit to change colour. This is no easy feat because the viral proteins are scarce and vastly outnumbered by the other kinds of proteins in clinical samples, making accurate testing quite challenging. Prof Preiser says: "Finally, there is the requirement to put this all together into the simplest possible device that can be easily deployed for testing of a large number of samples." He adds that the development of the rapid diagnostic test kit had harnessed the efforts of many scientists, such as Associate Professor Hadley Sikes and her team at the Massachusetts Institute of Technology (MIT), and Dr Patthara Kongsuphol from Smart - MIT's research enterprise here. He says: "We have now pooled all our expertise and resources to deliver a diagnostic device that ultimately is better, more reliable and cheaper than the current approaches." The test has already been tested and validated in laboratory settings. The next step, say the researchers, is to perform these tests with clinical samples to determine the sensitivity and specificity. Separately, another research team led by Assistant Professor Tan Meng How from the NTU School of Chemical and Biomedical Engineering is also working on a point-of-care diagnostic test kit that could yield results in 20 to 30 minutes. Like PCR test kits, the one being developed by Prof Tan and his team recognise the viral RNA. But instead of using a PCR machine to highlight the presence of the virus, the test being developed makes use of a gene-editing tool known to scientists as Crispr-Cas. This tool essentially works like a pair of "molecular scissors", says Prof Tan. "It can be programmed to cut a specific part of the viral RNA unique to Sars-CoV-2." The virus RNA is essentially made up of an "alphabet" of molecules known as nucleotides. The way this "alphabet" is ordered is unique to the virus, differentiating it from other types of viruses. Once the molecular scissors detects a specific segment of the viral RNA and snips it off from the rest of the viral genome, it becomes hyperactivated and starts to randomly cut snippets from other detectable genetic material in the sample. This trait was crucial for the scientists. It enabled them to put in a molecule that would start to glow only if its genetic "off" switch, which regulates gene expression, was snipped off. Prof Tan says: "If a fluorescent signal is detected, it indicates the presence of the virus. If not, it means the virus is not present to cause the hyperactivation of the molecular scissors." He adds that the test works in a laboratory setting with synthesised strains of the virus, but the next step is to obtain real patient samples to validate the test. "To me, this is like national service. If we have a technology in hand that can potentially help curb disease transmission, then we really have to try it."
|
||||
| Useful To Me Not Useful To Me | |||||
|
ST3-trading
Senior |
03-May-2020 13:34
|
||||
|
x 0
x 0 Alert Admin |
hahaha . V true
|
||||
| Useful To Me Not Useful To Me | |||||
|
ken777
Veteran |
03-May-2020 12:22
|
||||
|
x 0
x 0 Alert Admin |
Then Aytu should be a better choice to invest than Biolidics because in US market the ROI is much better in SG market.
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
ST3-trading
Senior |
03-May-2020 10:37
|
||||
|
x 0
x 0 Alert Admin |
https://www.cardinalhealth.com/en/cmp/ext/med/med-lab/aytu-covid-19-igm-igg-rapid-test-cassette.html they are sharing some news for aytu , that the test kits sellinf at cardinal health which its company supply medical product to 75per cent of hospital in US just sharing |
||||
| Useful To Me Not Useful To Me | |||||
|
ST3-trading
Senior |
02-May-2020 09:10
|
||||
|
x 0
x 0 Alert Admin |
https://www.jetro.go.jp/biznews/2020/04/3f8a6a8201904e56.html nothing much, just the company is mentioned at MAS report |
||||
| Useful To Me Not Useful To Me | |||||
|
lailai
Elite |
02-May-2020 08:11
|
||||
|
x 0
x 0 Alert Admin |
True, without announcing more sales figure, hard for potential buyers to gauge Bio' s mkt penetration success. Boss has to be quick like it' s Rapid test kit to team up with reliable distributors, as there are many other test kits vying for the booming mkt. Many countries are easing the lockdown to rekindle their economy, and demand of such kits is huge. The early birds will catch the worms lah. Few worms left for the late boss lah. 
|
||||
| Useful To Me Not Useful To Me | |||||
|
ST3-trading
Senior |
01-May-2020 22:05
|
||||
|
x 0
x 0 Alert Admin |
HOPefully. and announce more order to shareholders....
|
||||
| Useful To Me Not Useful To Me | |||||
|
Sgvale
Supreme |
01-May-2020 20:55
|
||||
|
x 0
x 0 Alert Admin |
500,000 rapid tests kits are initial order for market penetration. Once found reliable, Aytu will order even more than the committed 1.5million kits. | ||||
| Useful To Me Not Useful To Me | |||||
|
StevenKan
Master |
01-May-2020 20:33
|
||||
|
x 0
x 0 Alert Admin |
Aligned and same picture.... it is ok... sip sip tea.... pung bi bi...
|
||||
| Useful To Me Not Useful To Me | |||||
|
ST3-trading
Senior |
01-May-2020 20:15
|
||||
|
x 0
x 0 Alert Admin |
Actually HK sales figure nv report . | ||||
| Useful To Me Not Useful To Me | |||||
|
wokiechewbacca
Member |
01-May-2020 20:11
|
||||
|
x 0
x 0 Alert Admin |
I think you guys misinterpret.. the 500k mentioned here was delayed due to ban/backlog in China and then finally cleared. then the article continues... " along with the additional supply we have secured through our new rs with Biolidics..." this one should be another batch and should be shipped out of SG, not from China. Sounds like 2 diff things leh. bio did mention they got clearance from SG gov to export and ship this product. why they need to do that if it' s direct from China-US? i think bio must have value add in some way, cause the kits are marked " Biolidics" and doesn' t make sense to do China-sg-us? Which co so kumgong do this kind of thing unless there is valid reason for the kits to come in sg first.
|
||||
| Useful To Me Not Useful To Me | |||||